When trading opened in 2019, investors were just hoping stocks would produce a rebound from the awful fourth quarter in 2018. But Apple (NASDAQ:AAPL) nearly spoiled...
Shares of Pain Therapeutics, Inc. (NASDAQ:PTIE) and partner, Durect Corp. (NASDAQ:DRRX) , plunged following the news that a joint meeting of the Anesthetic and Analgesic Drug...
Summary AcelRx develops Zalviso to treat acute and breakthrough pain. We believe there is a 90% chance the company receives FDA approval on July 27. Zalviso has several advantages...
U.S. stocks finished the week mixed, with the Nasdaq Composite index climbing to a moderate advance and the S&P 500 recouping about half of Thursday's six-point loss. Healthcare...